Targeting apoptosis signaling in pancreatic cancer

  • The ability to escape apoptosis or programmed cell death is a hallmark of human cancers, for example pancreatic cancer. This can promote tumorigenesis, since too little cell death by apoptosis disturbs tissue homeostasis. Additionally, defective apoptosis signaling is the underlying cause of failure to respond to current treatment approaches, since therapy-mediated antitumor activity requires the intactness of apoptosis signaling pathways in cancer cells. Thus, the elucidation of defects in the regulation of apoptosis in pancreatic carcinoma can result in the identification of novel targets for therapeutic interference and for exploitation for cancer drug discovery. Keywords: apoptosis; pancreatic cancer; TRAIL; IAPs; mitochondria

Download full text files

Export metadata

Metadaten
Author:Simone FuldaORCiDGND
URN:urn:nbn:de:hebis:30-100343
DOI:https://doi.org/doi:10.3390/cancers3010241
ISSN:2072-6694
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/24212616
Parent Title (English):Cancers
Publisher:MDPI
Place of publication:Basel
Document Type:Article
Language:English
Date of Publication (online):2011/08/08
Date of first Publication:2011/01/11
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2011/08/08
Tag:IAPs; TRAIL; apoptosis; mitochondria; pancreatic cancer
Volume:3
Issue:1
Page Number:11
First Page:241
Last Page:251
Note:
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
HeBIS-PPN:272541575
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 3.0